County
Haywood County EMS System
Haywood County EMS System (NC) carries 50 drugs across 155 dose entries in its current published protocol, effective 2026-04-01.
Drugs and doses50
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 200 |
| Fever | adult | 325–1000 mg | IV/IO | not captured | standing | page 200 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 200 |
| Fever | peds | 15 mg/kg | IV/IO | not captured | standing | page 200 |
| Mild to moderate pain | adult | 15 mg/kg | IV/IO | not captured | standing | page 201 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 201 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 201 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 156 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 156 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 23, 25, 104, 106 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 25, 104, 106 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2.5–5 mg | NEB | not captured | standing | pages 49, 115 |
| Allergic reaction | peds | 2.5–5 mg | NEB | not captured | standing | pages 49, 115 |
| Asthma / bronchospasm | adult | 2.5–5 mg | NEB | not captured | standing | pages 79, 85 |
| Asthma / bronchospasm | peds | 1.25–2.5 mg | NEB | not captured | standing | pages 79, 85 |
| Croup | adult | 2.5–5 mg | NEB | not captured | standing | pages 79, 85 |
| Croup | peds | 1.25–2.5 mg | NEB | not captured | standing | pages 79, 85 |
Alteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | 10% of total dose as initial bolus | IV | not captured | standing | page 58 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 29, 108 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 29, 108 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 23, 25, 107 |
| Narrow-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 23, 25, 107 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 19 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 15, 99 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 15, 99 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | page 158 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 53, 167 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 53, 167 |
Casirivimab
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | IV | not captured | standing | page 134 |
| Other | adult | 600 mg | SQ | not captured | standing | page 134 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 169 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | pages 57, 120 |
| Adrenal crisis | peds | 5 mg | IV/IO/IM | not captured | standing | pages 57, 120 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 125 mL | IV/IO | not captured | standing | pages 51, 117 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | pages 51, 117 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 132 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 205 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 205 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 23 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | pages 49, 115 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 49, 115 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | pages 49, 115 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 49, 115 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 15 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 56, 119 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV/IO | not captured | standing | pages 56, 119 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 132 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 49, 115 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 49, 115 |
| Bradycardia | adult | 1–10 mcg | IV/IO | not captured | standing | page 15 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 99 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 13, 29, 97, 108 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 13, 29, 97, 108 |
| Croup | peds | 1 mg | NEB | not captured | standing | pages 79, 85 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 77 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 50–100 mcg | IV/IO | not captured | standing | page 19 |
| CHF / pulmonary edema | peds | 1 mcg/kg | IV/IO | not captured | standing | page 101 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM | not captured | standing | page 201 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 201 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV/IO | not captured | standing | pages 41, 101 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV/IO | not captured | standing | pages 41, 101 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 156 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 156 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | pages 51, 117 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 51, 117 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IM | not captured | standing | page 215 |
| Agitation | adult | 2–5 mg | IM | not captured | standing | page 215 |
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 132 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | pages 57, 120 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 57, 120 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 132 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–600 mg | PO | not captured | standing | page 200 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 200 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 201 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 201 |
Imdevimab
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | IV | not captured | standing | page 134 |
| Other | adult | 600 mg | SQ | not captured | standing | page 134 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | pages 49, 115 |
| Allergic reaction | peds | 0.5 mg | NEB | not captured | standing | pages 49, 115 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 79, 85 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 79, 85 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | pages 216, 217 |
| Hyperactive delirium | peds | 2 mg/kg | IM | not captured | standing | pages 216, 217 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 201 |
| RSI induction | adult | 1–2 mg/kg | IV/IO | not captured | standing | pages 77, 78 |
| RSI induction | peds | 1–2 mg/kg | IV/IO | not captured | standing | pages 77, 78 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IO | not captured | standing | page 201 |
| Severe pain | adult | 30 mg | IM | not captured | standing | page 201 |
| Severe pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 201 |
| Severe pain | peds | 0.5 mg/kg | IM | not captured | standing | page 201 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 29, 108 |
| Cardiac arrest | peds | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 29, 108 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 132 |
| Seizure | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 205 |
| Seizure | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 205 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 79, 85 |
| Asthma / bronchospasm | peds | 40 mg/kg | IV/IO | not captured | standing | pages 79, 85 |
| Cardiac arrest | adult | 2 g | IV/IO | not captured | standing | pages 29, 108 |
| Cardiac arrest | peds | 2 g | IV/IO | not captured | standing | pages 29, 108 |
| Narrow-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | pages 27, 28, 85, 108 |
| Narrow-complex tachycardia | peds | 40 mg/kg | IV/IO | not captured | standing | pages 27, 28, 85, 108 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 57, 120 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 57, 120 |
| Allergic reaction | adult | 125 mg | IV/IO | not captured | standing | pages 49, 115 |
| Allergic reaction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 49, 115 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 79, 85 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 79, 85 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 215 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 215 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 215 |
| Agitation | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 215 |
| Hyperactive delirium | adult | 10 mg | IM | not captured | standing | page 216 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 216 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 15 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IN | not captured | standing | pages 23, 25, 27, 104, 106 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | pages 23, 25, 27, 104, 106 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 205 |
| Seizure | adult | 2–2.5 mg | IV/IO | not captured | standing | page 205 |
| Seizure | adult | 5 mg | IN | not captured | standing | page 205 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 205 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 205 |
| Seizure | peds | 0.2 mg/kg | IN | not captured | standing | page 205 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV/IO | not captured | standing | page 19 |
| CHF / pulmonary edema | adult | 2–4 mg | IV/IO | not captured | standing | page 101 |
| CHF / pulmonary edema | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 101 |
| Mild to moderate pain | adult | 2 mg | IV/IM/SQ | not captured | standing | page 132 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | page 17 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/ET | not captured | standing | page 17 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 17 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 17 |
Nicardipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | 2.5 mg | IV | not captured | standing | page 58 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.3–0.4 mg | SL | not captured | standing | page 19 |
| CHF / pulmonary edema | adult | 0.3–0.4 mg | SL | not captured | standing | page 21 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–30 mcg | IV/IO | not captured | standing | pages 56, 57, 119 |
| Hypotension / shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | pages 56, 57, 119 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 187 |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 187 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 187 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 187 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1/2 to 1 Tube | PO | not captured | standing | pages 51, 117 |
| Hypoglycemia | peds | 1/2 to 1 Tube | PO | not captured | standing | pages 51, 117 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | pages 49, 115, 198 |
| Other | peds | 2 spray | IN | not captured | standing | pages 49, 115, 198 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | pages 158, 159 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 25 mg | IV/IM | not captured | standing | page 132 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 77 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 53, 167 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 53, 167 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 156 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 156 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 1–2 g | IV/IO | not captured | standing | pages 69, 172 |
| Other | adult | 10 mL | TOP | not captured | standing | pages 198, 199 |
| Trauma / hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | pages 69, 172 |
| Trauma / hemorrhage | adult | 10 mL | TOP | not captured | standing | pages 195, 196 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 87 |